Hikal Ltd
NSE:HIKAL
Hikal Ltd
EPS (Diluted)
Hikal Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hikal Ltd
NSE:HIKAL
|
EPS (Diluted)
₹6
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
EPS (Diluted)
₹64
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
EPS (Diluted)
₹61
|
CAGR 3-Years
25%
|
CAGR 5-Years
24%
|
CAGR 10-Years
15%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
EPS (Diluted)
₹47
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
EPS (Diluted)
₹55
|
CAGR 3-Years
15%
|
CAGR 5-Years
27%
|
CAGR 10-Years
8%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
EPS (Diluted)
₹47
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikal Ltd
Glance View
Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.
See Also
What is Hikal Ltd's EPS (Diluted)?
EPS (Diluted)
6
INR
Based on the financial report for Dec 31, 2024, Hikal Ltd's EPS (Diluted) amounts to 6 INR.
What is Hikal Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-4%
Over the last year, the EPS (Diluted) growth was 4%. The average annual EPS (Diluted) growth rates for Hikal Ltd have been -27% over the past three years , -4% over the past five years .
You don't have any saved screeners yet